Metastasis Research Network (U54 Clinical Trial Not Allowed)
The summary for the Metastasis Research Network (U54 Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Metastasis Research Network (U54 Clinical Trial Not Allowed): Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on developing a comprehensive and cohesive understanding of cancer metastasis. Towards this goal, the NCI will support U54 Specialized Centers that together will continue to serve as the hub of the Metastasis Research Network (MetNet). Each MetNet Center should propose an overarching scientific theme that will be pursued through two or three scientific inter- and multidisciplinary basic research projects. The projects should use integrative system level approaches to elucidate and integrate a mechanistic understanding of the non-linear, dynamic, and emergent processes in metastasis. Overarching themes should encompass the interplay between at least two central elements in the metastatic process such as early dissemination, cellular, soluble and/or physical microenvironment crosstalk, dormancy, or mechanisms of responses by metastatic cells to therapies. Studies on all types of cancer are welcome, including rare and pediatric metastatic cancers.Research proposed by MetNet Centers is expected to advance our understanding towards a more comprehensive appreciation of metastasis as a whole body, systems-level problem.
| Federal Grant Title: | Metastasis Research Network (U54 Clinical Trial Not Allowed) |
| Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-CA-27-012 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 93.396 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | September 25th, 2026 |
| Original Application Deadline: | September 25th, 2026 |
| Posted Date: | June 4th, 2026 |
| Creation Date: | June 4th, 2026 |
| Archive Date: | November 24th, 2026 |
| Total Program Funding: | $6,800,000 |
| Maximum Federal Grant Award: | $1,300,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | 4 |
| Cost Sharing or Matching: | No |
| Last Updated: | June 4th, 2026 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Grant Announcement Contact
- NCI MetNet Research Program
[email protected]
[email protected] - Similar Government Grants
- • The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not...
- • New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Opt...
- • Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional...
- • Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional...
- • Mouse Models of Human Cancers Consortium
- • Integrative Cancer Biology Programs
- • Memory T Lymphocytes in Cancer Immunology (R21)
- More Grants from the National Institutes of Health
- • Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial...
- • Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VC...
- • Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)
- • Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal ...
- • PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine...
